These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16239318)

  • 1. Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-alpha and the neutrophil/lymphocyte ratio.
    Ibáñez L; Valls C; de Zegher F
    Hum Reprod; 2006 Feb; 21(2):451-6. PubMed ID: 16239318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception.
    Ibáñez L; Jaramillo AM; Ferrer A; de Zegher F
    Hum Reprod; 2005 Sep; 20(9):2457-62. PubMed ID: 15905296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
    Ibáñez L; de Zegher F
    Hum Reprod Update; 2006; 12(3):243-52. PubMed ID: 16407452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
    Ibáñez L; De Zegher F
    Hum Reprod; 2004 Aug; 19(8):1725-7. PubMed ID: 15229206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women.
    Ibáñez L; de Zegher F
    Fertil Steril; 2006 Jul; 86 Suppl 1():S24-5. PubMed ID: 16798281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2005 Jan; 90(1):39-43. PubMed ID: 15483105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin.
    Ibáñez L; López-Bermejo A; Díaz M; Enríquez G; Valls C; de Zegher F
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):317-20. PubMed ID: 18031315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.
    Ibáñez L; De Zegher F
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4720-4. PubMed ID: 14557446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess.
    Ibáñez L; López-Bermejo A; del Rio L; Enríquez G; Valls C; de Zegher F
    J Clin Endocrinol Metab; 2007 May; 92(5):1710-4. PubMed ID: 17299064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent effects of ethinylestradiol-drospirenone and flutamide-metformin on follistatin in adolescents and women with hyperinsulinemic androgen excess.
    Ibáñez L; Díaz M; López-Bermejo A; de Zegher F
    Gynecol Endocrinol; 2011 Mar; 27(3):197-8. PubMed ID: 20528210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.
    Ibáñez L; Valls C; Cabré S; De Zegher F
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4716-20. PubMed ID: 15356085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months.
    Ibáñez L; López-Bermejo A; Díaz M; Enríquez G; del Río L; de Zegher F
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):351-7. PubMed ID: 19018783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome.
    Ibáñez L; de Zegher F
    Hum Reprod; 2003 Jan; 18(1):57-60. PubMed ID: 12525441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.
    Ibáñez L; Valls C; Ferrer A; Ong K; Dunger DB; De Zegher F
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2870-4. PubMed ID: 12050266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
    Chen YG; Xu F; Zhang Y; Ji QS; Sun Y; Lü RJ; Li RJ
    Chin Med J (Engl); 2006 Jan; 119(1):32-6. PubMed ID: 16454979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
    Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.
    Mulligan K; Yang Y; Wininger DA; Koletar SL; Parker RA; Alston-Smith BL; Schouten JT; Fielding RA; Basar MT; Grinspoon S
    AIDS; 2007 Jan; 21(1):47-57. PubMed ID: 17148967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines.
    Ansari G; Mojtahedzadeh M; Kajbaf F; Najafi A; Khajavi MR; Khalili H; Rouini MR; Ahmadi H; Abdollahi M
    Adv Ther; 2008 Jul; 25(7):681-702. PubMed ID: 18636232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.